Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Applied Therapeutics, Inc. - Common Stock (NQ:APLT)

0.4901 -0.1099 (-18.32%)
Streaming Delayed Price Updated: 1:46 PM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,609,866
Open 0.5800
Bid (Size) 0.4900 (35)
Ask (Size) 0.4901 (14)
Prev. Close 0.6000
Today's Range 0.4703 - 0.5800
52wk Range 0.2950 - 10.62
Shares Outstanding 114,846,271
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Top stock movements in today's session.
Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill

Performance

YTD
-45.4%
-45.4%
1 Month
+47.4%
+47.4%
3 Month
-16.8%
-16.8%
6 Month
-94.3%
-94.3%
1 Year
-88.3%
-88.3%

More News

Read More
Gapping stocks in Monday's session
Via Chartmill
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
From Applied Therapeutics
Via GlobeNewswire
Applied Therapeutics Reports First Quarter 2025 Financial Results
From Applied Therapeutics
Via GlobeNewswire
Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
From Applied Therapeutics
Via GlobeNewswire
Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results
From Applied Therapeutics
Via GlobeNewswire
Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission
From Applied Therapeutics
Via GlobeNewswire
Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer
From Applied Therapeutics
Via GlobeNewswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics
From Faruqi & Faruqi, LLP
Via Business Wire
Final APLT Deadline Reminder: February 18, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Final APLT Deadline Reminder: February 18, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
APLT Deadline in 1 Day: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
APLT Deadline in 1 Day: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
APLT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLT
From The Rosen Law Firm PA
Via GlobeNewswire
DEADLINE TOMORROW: Kaplan Fox Reminds Investors of a Deadline for a Securities Class Action Lawsuit Against Applied Therapeutics (APLT)
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
DEADLINE TOMORROW: Kaplan Fox Reminds Investors of a Deadline for a Securities Class Action Lawsuit Against Applied Therapeutics (APLT)
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
APLT Deadline: Rosen Law Firm Urges Applied Therapeutics, Inc. (NASDAQ: APLT) Investors to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
APLT Deadline in 3 Days: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
APLT Deadline in 3 Days: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal
Kaplan Fox Reminds Investors of a Deadline for a Securities Fraud Class Action Lawsuit Against Applied Therapeutics (APLT)
Via TheNewswire.com
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Kaplan Fox Reminds Investors of a Deadline for a Securities Fraud Class Action Lawsuit Against Applied Therapeutics (APLT)
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Deadline Soon: Applied Therapeutics, Inc. (APLT) Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
From The Law Offices of Frank R. Cruz
Via Business Wire
Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit Against Applied Therapeutics (APLT)
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit Against Applied Therapeutics (APLT)
Via TheNewswire.com
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety

Frequently Asked Questions

Is Applied Therapeutics, Inc. - Common Stock publicly traded?
Yes, Applied Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Applied Therapeutics, Inc. - Common Stock trade on?
Applied Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Applied Therapeutics, Inc. - Common Stock?
The ticker symbol for Applied Therapeutics, Inc. - Common Stock is APLT on the Nasdaq Stock Market
What is the current price of Applied Therapeutics, Inc. - Common Stock?
The current price of Applied Therapeutics, Inc. - Common Stock is 0.4901
When was Applied Therapeutics, Inc. - Common Stock last traded?
The last trade of Applied Therapeutics, Inc. - Common Stock was at 05/19/25 01:46 PM ET
What is the market capitalization of Applied Therapeutics, Inc. - Common Stock?
The market capitalization of Applied Therapeutics, Inc. - Common Stock is 56.29M
How many shares of Applied Therapeutics, Inc. - Common Stock are outstanding?
Applied Therapeutics, Inc. - Common Stock has 56M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.